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INTRODUCTION
The incidence of food allergies has increased significantly in the
past decades and is currently a worldwide public health problem.
Gastrointestinal food allergies in neonates, infants and young chil-
dren are due to developmental immaturity of various components
of the gut barrier and gut immune system (1) and exhibit a variety
symptoms and disorders involving the skin and gastrointestinal and
respiratory tracts (2).
The gut-associated lymphoid tissue organized in solitary and
aggregate follicles within the gut plays a central role in defense
against many invading pathogens and the development of immune-
tolerance against food allergy (3-7). The immune system is mainly
mediated through B cells, producing secretory IgA (SIgA) which
acts as a blocking or neutralizing antibody (8-12). To monitor the
immunological maturity of the gut, it is important to measure antigen-
or allergen-specific SIgA levels in stool of patients with gastroin-
testinal food allergies and assess immunotolerance of allergy in
the mucosa (13, 14). For accurate quantitative measurement of SIgA
in stool, the roles of pancreatic enzymes should be taken into con-
sideration, such as trypsin, chymotrypsin (15, 16), and various im-
munoglobulin-degrading proteases, such as IgA1, IgA2, SIgA or IgG
proteases, in Escherichia coli (17, 18) and other microbiota in stool.
The present study is an extension to our previous study on our
new sensitive allergen-microarray for monitoring various immuno-
globulin parameters in serum and saliva (19-23), and was designed
to detect SIgA in stool. Specifically, we used the densely carboxylated
protein chip (DCP chip), with modified carboxylated arms on the
surface of the diamond-like carbon-coated chip (19) or the sur-
face of the glass slide chip. In this study, we used the glass slide
DCP chip to detect allergen-specific SIgA in stool.
MATERIALS AND METHODS
Materials
Phenylmethylsulfonyl fluoride (PMSF), leupeptin, Bestatin, E-
64c, aprotinin, chymostatin and ethylenediaminetetraacetic acid
(EDTA) were purchased from Sigma (St. Louis, MO). Protease sub-
strates, t -butyloxycarbonyl (Boc)-L-Phe-Ser-Arg 4-methylcou-
maryl -7 -amide (MCA), Leu-MCA, benzyloxycarbonyl (Z)-L-Phe-
Arg-MCA and (7-methoxycoumarin-4-yl) acetyl (MOCAc)-L-
Arg-Pro-Lys-Pro-Tyr-Ala-norvalyl (Nva)-Trp-Arg-N ε - (2,4 -dini-
trophenyl) -L-Lys (Lys(Dnp))-NH2 were purchased from Peptide
Institute (Osaka, Japan).
Sample collection
Stool samples were collected from 10 healthy neonates, infants
and toddlers (age, 0-36 months), and immediately treated with or
without protease inhibitors, then stored at -30 until use. Stool
samples were also collected separately from another group of 20
one-month-old infants for analysis of the relationship between
serine protease activities and protease-mediated degradation of IgA
and SIgA. The mother of each neonate/infant/toddler gave in-
formed consent to sample collection. The study was approved by
the ethics committees of the National Research Institute for Child
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Measurement of allergen-specific SIgA
We used a glass slide DCP chip (Gene slide ; Toyo Kohan Co.
Tokyo, Japan) instead of a diamond-like carbon-coated DCP chip
(19) in this study to measure allergen-specific SIgA levels and
their immunoresponse profile.
Purified molecular allergens, including ovomucoid, ovalbumin,
conalbumin, α -casein, β -casein, κ -casein, α - lactoalbumin and β -
lactoglobulin, were purchased from Sigma-Aldrich (St Louis, MO).
The allergen solutions of ovomucoid (1 mg/ml), ovalbumin (0.5
mg/ml), conalbumin (1 mg/ml), α -casein (1 mg/ml), β -casein
(1 mg/ml), κ -casein (0.25 mg/ml), α - lactoalbumin (1 mg/ml) and
β - lactoglobulin (1 mg/ml) in 4.4 nl, were spotted tetraplicates and
immobilized by covalent binding on the chip. Human IgA (67/086),
as an internal standard on the chip, was obtained from the National
Institute for Biological Standards (Hertfordshire, UK). The aller-
gen microarrays were incubated with 20 μl of stool extracts for 60
min at 37, and then SIgA antibodies bound on each allergen was
visualized by HiLyte Fluor 555 (Dojindo Molecular Technologies,
Kumamoto, Japan)- labeled secondary antibody (Life Technologies,
Gaithersburg, MD) against human IgA for 60 min at 37, which
reacts both SIgA and IgA. The immunofluorescence intensity of
each allergen was analyzed using FLA-8000 scanner (Fujifilm Co.,
Tokyo) with an excitation wavelength of 532 nm and emission wave-
length of 570 nm under 60% impressed voltage, as described pre-
viously (19-23).
Stool sample extraction
Stool samples (100 mg) in extraction buffer (5 ml) of the EDN
ELISA Kit (MBL, Nagoya, Japan) (24), were suspended for few
min and then insoluble materials were removed by centrifugation
at 13000g for 5 min at 4. The supernatant was stored at -30
until use. Stool extracts were diluted to 0.25 mg protein/ml using
phosphate-buffered saline (PBS), containing 1% bovine serum
albumin (BSA), 0.3 M KCl and 0.05% Tween 20. The levels of al-
lergen-specific SIgA in the stool extract were analyzed on the
glass slide DCP chip.
Measurement of activities of various proteolytic enzymes in stool
extracts
The activities of various proteolytic enzymes in the stool extracts
were measured using the modified methods described previously
(25-28). The activity of trypsin-type protease was measured by the
hydrolysis of 20 μMBoc-Phe-Ser-Arg-MCA in 0.1 M Tris-HCl
buffer, pH 8.0, at 37 for 10 min. The activity of amino-peptidase
was monitored by the hydrolysis of 50 μM Lue-MCA in 0.1 M
Tris-HCl buffer, pH 7.4, at 37 for 10 min. The activity of cysteine
protease was assayed by the hydrolysis of 20 μM Z-Phe-Arg-MCA
in 0.1 M acetic buffer, pH 4.0, containing 10 mM cysteine at 37
for 10 min. The activity of metalloprotease was analyzed by the hy-
drolysis of 10 μMMOCAc-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-
Met-Lys (Dnp)-NH2 in 0.1 M Tris-HCl buffer, pH 7.4, containing
0.15 M NaCl, 10 mM CaCl2 at 37 for 10 min. The enzyme activ-
ity was measured as fluorescence (excitation at 370 nm, emission
at 460 nm) using a plate reader (Total reaction volume is 200 μl,
Spectra max GEMINI EM 200, Molecular Devices, Sunnyvale, CA).
One unit of enzyme activity was defined as the amount of the ac-
tivity that released 1 μmol of MCA from the substrate per min.
Reduction of allergen immunoreactivity by stool samples
Stool extracts were applied onto the allergen chip, incubated
at 37 for 60 min and then washed. Pooled sera containing aller-
gen-specific IgA from allergic patients were applied on the chip to
measure the immunoreactivity of allergens, incubated at 37 for
60 min and then washed. The levels of allergen-specific SIgA were
then analyzed by IgA immunofluorescence intensity.
Reduction of immunoreactivity of allergen-specific SIgA by stool
protease(s)
To analyze the stability of allergen-specific SIgA in stool, stool
extracts were prepared as follows. Stool extracts were sonicated
with 30 bursts of 15 sec at 4 using bath-type sonicator (Bioruptor
UCW-310, Cosmo Bio Co., Tokyo), and incubated by flopping up-
side down at 4 for 60 min. Next, the insoluble materials were
removed by centrifugation at 17400g at 4 for 10 min. After fil-
tration of the supernatant through 0.45 μm pore-size filter (Kurabo,
Osaka, Japan), the filtrates were incubated for the indicated time
intervals (from 0 to 24 hr). After incubation, the activities of vari-
ous proteases in stool were stopped by the addition of protease
inhibitor cocktail containing 10 mM PMSF, 0.1 mM leupeptin, 0.1
mM bestatin and 0.1 mM E-64c in PBS buffer containing 15% di-
methylsulfoxide, 0.3 M KCl and 0.05% Tween 20. The concentra-
tion of proteins in the extracts was then adjusted to 2.5 mg/ml by
PBS containing 10% BSA, 0.3 M KCl and 0.05% Tween 20. After the
reaction, the stool extracts were incubated with allergen-microarray
for 60 min and the immunofluorescence intensity of allergen-spe-
cific SIgA bound on each allergen was measured by a HiLyte Fluor
555- labeled secondary antibody after further incubation for 60 min
at 37.
Statistical analysis
Statistical analysis was performed using SPSS software (SPSS,
Chicago, IL, USA). Paired correlations were analyzed for signifi-
cance by the spearman rank test.
RESULTS
Activities of various protease in stools of neonates, infants and
toddlers
The gastrointestinal tract of neonates, infants and toddlers un-
dergoes marked structural and functional adaptation in response
to feeding and the rapid and large changes are characterized by
induction of digestive proteases in the gastrointestinal tract, devel-
opment of intestinal microbiota and mucosal immunity. All such
changes should be reflected in stool samples. We analyzed the pro-
teolytic activities of serine proteases, cysteine proteases, aminopep-
tidases and metalloproteases in stool samples of neonates, infants
and toddlers aged 0-28 days, 6-7 months and 1-3 years (Table 1).
The activities of serine proteases and metalloproteases in stool
extracts increased markedly to about 8 to 9 folds and 6 to 7 folds,
respectively, at the weaning period of 6-7 months of age and the
levels were still high at 1-3 years of age. On the other hand, the
activities of cysteine proteases and amino-peptidases were only
slightly increased (to about 2- fold) at the weaning period (Table 1).
Stool samples from 1-month-old infants but not 3-day-old neo-
nates reduce IgA immunofluorescence signals
Although relatively low levels of protease activities were detected
in stool samples of neonates and infants, we examined the effects
of stool proteases on IgA, allergen-specific SIgA and allergens on
the chip.
To analyze the levels of milk and egg allergen-specific SIgA in
the stool, molecular allergens and various doses of WHO human
IgA standards (0.05-10 IU/ml) were spotted in tetraplicates on the
glass DCP chip and immobilized as described previously (19) (Fig.
1A). After incubation with stool extracts on the chip for various time
periods (0-60 min), SIgA captured on allergens and standard IgAs
were visualized with HiLyte FluorTM 555 labeled anti -human IgA
with rainbow display. To our surprise, no allergen-specific SIgA
signal was detected with stool extract of 1-month-old infants and
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Table 1. Activity of various proteases in stools of neonates, infants and toddlers.
Enzyme activity
Serine protease
( mU/μg )
Cysteine protease
( mU/μg )
Amino peptidase
(mU/μg )
Metalloprotease
(FLR/μg)
0-28 days (n=3) 17.04.6 0.080.04 3.93.1 466485
6-7 months (n=3) 15473 0.160.03 9.85.9 34111141
1-3 years (n=4) 143.287.4 0.110.05 14.06.1 2593662
Values are meansSD of three or four separate stool samples of neonates, infants and toddlers.
Fig. 1. Reduction of immunofluorescence intensities of IgA by protease(s) in stool of neonates and infants.
A : Rainbow displays of fluorescence intensities of SIgA and IgA on the protein chip after reaction with stool extracts (0.25 mg/mL) of 3 -day -old
neonate and 1-month-old infant. B : Serine protease activity (mU/μg protein) in stool extracts of 1 -month-old infants (n=20) was measured and
divided into group A (activities below 10 mU/μg protein, n=7), group B (activities between 10 and 30 mU/μg protein, n=11) and group C (activi-
ties above 31 mU/μg protein, n=2). Data represent the meanSD of the number of stool samples in each group. C : Time courses of percent re-
duction in immunofluorescence signals of standard IgA were analyzed after incubation with each representative stool extract in group A (0.4 mU/
μg protein), B (28.1 mU/μg protein) and C (59.1 mU/μg protein). The immunofluorescence intensity of IgA at 0 time was set at 100%. Data rep-
resent the meanSD of the tetraplicates spotted standard IgA. D : Relationship between serine protease activity in stool and immunofluorescence
of IgA. Stool extracts of 1 -month-old infants (n=20) were incubated with allergen chips for 10 min and the percent reduction of immunofluores-
cence signals of standard IgA (10 IU/ml) was analyzed. Control immunofluorescence intensity of IgA in the absence of stool extract was set at 100%.
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the immunofluorescence signals of WHO IgA standards were mark-
edly reduced on the chip, compared with the control (no stool)
and with stool of 3-day-old neonate. These data suggest that stool
protease(s) degrades IgA standards, SIgA captured on allergens
and/or allergens.
Since the major IgA-degrading protease(s) in stool of neonates,
infants and toddlers is the Boc-Phe-Ser-Arg-MCA hydrolyzing
trypsin-type serine protease(s) (see below), we measured the ac-
tivities of trypsin-type serine proteases in 20 stool samples, pre-
pared separately from 1-month-old infants, and divided into three
groups : group A, (activities below 10 mU/μg protein), group B
(activities between 10 and 30 mU/μg protein) and group C (ac-
tivities above 31 mU/μg protein) (Fig. 1B). Fig. 1C shows the time
course of reduction of immunofluorescence intensity of standard
IgA (10 IU/mL) in the presence of representative stool samples
from each group. While the fluorescence intensity of IgA in sample
A did not change throughout the 60-min incubation at 37, the
intensities in samples B and C rapidly and markedly decreased
within 10-min incubation and remained low for up to 60 min. Fig.
1D shows the negative and significant correlation between stool
serine protease activity and IgA fluorescence intensity after 10-min
incubation (rs= -0.88 ; p0.001).
Effects of protease inhibitors on stool-induced reduction of IgA
immunofluorescence intensity
In the next step, we used various protease inhibitors to deter-
mine the exact protease responsible for the reduction of IgA im-
munofluorescence intensity induced by stools of 1-month-old
infants. In the absence of protease inhibitors, stool reduced IgA
fluorescence to about 10-25% of that of the control (no stool).
Among the protease inhibitors tested, PMSF at 1 mM almost com-
pletely inhibited the reduction by tool extracts (0.25 mg protein/
ml) whereas no significant inhibitory effects were detected by
other inhibitors (Fig. 2A). PMSF is known to inhibit the activities
of serine proteases, such as trypsin, chymotrypsin and thrombin,
and cysteine protease papain but not other cysteine proteases and
metalloproteases (29). The inhibitory effects of PMSF on the re-
duction of IgA immunofluorescence were dose-dependent, and
concentrations of 0.5 mM and higher resulted in complete sup-
pression (Fig. 2B). Thereafter we used 1 mM PMSF for the stool
extracts at protein concentration of 0.25 mg/ml and 10 mM PMSF
for those at protein concentration of 2.5 mg/ml.
We also tested the effects of various protease inhibitors on re-
duction of IgA immunofluorescence intensity induced by stools of
6-7 -months-old infants and 1-3-years-old toddlers. These stool
extracts also reduced IgA immunofluorescence, and PMSF did not
result in complete inhibition (Fig. 3A and B). Instead, the stool -
induced reduction was completely abrogated by a protease inhibi-
tor mixture containing 1 mM PMSF, 0.1 mM leupeptin, 0.1 mM
bestatin and 0.1 mM E-64c. To determine the effect of inhibitors
other than PMSF on the reduction, two stool samples with incom-
plete restoration of the immunofluorescence intensity of IgA with
PMSF in experiments A and B were selected and the effects of in-
hibitor combination with 1 mM PMSF were analyzed. Among the
tested combinations, 1 mM PMSF plus 0.1 mM leupeptin pro-
duced complete inhibition of the stool - induced reduction of IgA
immunofluorescence (Fig. 3C).
Reduction of allergen immunoreactivity by stool protease(s)
The protease(s) in stool of neonates, infants and toddlers can
degrade not only IgA and SIgA but also allergens immobilized on
the chip. Accordingly, we analyzed the loss of allergen immunore-
activity by stool of 1-month-old infants after incubation with the
allergen chip for 60 min at 37 and analyzed the allergen im-
munoreactivity. Reduction of allergen immunoreactivity was moni-
tored by serum IgA of patients with egg and milk allergy. The
immunofluorescence signals of allergens on the chip visualized by
allergen-specific IgA from sera of allergic patients were markedly
reduced by the stool extract and the reduced signals were almost
completely restored by the addition of 1 mM PMSF to the stool
extracts (Fig. 4A). The reduction of immunoreactivity and resto-
ration were analyzed for each allergen. Since ovomucoid and β -
lactoglobulin exhibit protease inhibitor activities, the immunofluo-
rescence signal was not or only mildly reduced, respectively.
However, the immunofluorescence signals of α -casein, β -casein,
κ -casein, milk and egg white allergens were markedly reduced
by the stool extracts but completely restored by 1 mM PMSF
(Fig. 4B).
We also analyzed the reduction of immunoreactivity of SIgA by
protease(s) in stool of 1-3 -year-old toddlers (n=4). Fig. 5 shows
representative results of loss of immunoreactivities against milk.
The immunofluorescence signals of milk allergen-specific SIgA in
the stool of four individuals were markedly reduced during 9-hr
incubation in the absence of the protease inhibitors.
Fig. 2. Effects of protease inhibitors on reduction of immunofluores-
cence intensity of IgA induced by stool of 1 -month-old infants.
A : Stools extracts (0.25 mg/ml) from 1-month-old infants (n=3) incu-
bated with or without protease inhibitors (1 mM PMSF, 0.1 mM leupeptin,
0.1 mM aprotinin, 0.1 mM E-64c, 0.1 mM bestatin, 1 mM EDTA and 0.1
mM chymostatin) in PBS containing 5% DMSO, 0.3 M KCl and 0.05%
Tween 20, were incubated with allergen chips for 60 min at 37and the
immunofluorescence intensities of standard IgA (10 IU/ml) were ana-
lyzed. The immunofluorescence intensity of IgA in the absence of stool
extract was set as 100%. Data represent the meanSD of the tetrapli-
cates spotted standard IgA. B : Effects of various doses of PMSF on the
immunofluorescence intensities of IgA (10 IU/ml). One stool sample
with the lowest immunofluorescence intensity without inhibitor in ex-
periment A at 12.0% was selected, incubated with various doses of PMSF
for 60 min at 37and then restoration of the immunofluorescence in-
tensities of IgA on the chip was analyzed. The intensity of IgA in the
absence of stool extract was set as 100%. Data represent the meanSD
of the tetraplicates spotted standard IgA.
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Detection of allergen-specific SIgA in stool of neonates and in-
fants
Under the experimental conditions of protease inhibitors stated
above, which protect against the degradation of allergens, IgA and
SIgA on the chip, we measured allergen-specific SIgA in stool
samples from 3-day-old neonate and 1-month-old infant on the
chip with protease inhibitor cocktail that contained 10 mM PMSF,
0.1 mM leupeptin and other protease inhibitors. Immunofluores-
cence signals of allergen-specific SIgA of egg white, ovalbumin,
α -casein, β -casein, κ -casein and milk were detected using stool
extracts (2.5 mg protein/ml) of 1-month-old infant (Fig. 6). How-
ever, the stool extract of 3-day-old neonate did not show such
immunofluorescence signals probably due to the lack of SIgA at
that age (30).
DISCUSSION
Analysis of the levels of allergen-specific immunoglobulins, cy-
tokines and allergens in the gut mucosa is important to understand
the status of gastrointestinal maturation and mucosal immunity,
particularly in patients with gastrointestinal food allergies. Food
allergies in neonates, infants and young children have increased
significantly in the past decades but there was no precise report of
the methods of stool immunoglobulin analysis.
In the present study, we measured allergen-specific SIgA in
stools of neonates, infants and toddlers using a new sensitive DCP
allergen-microarray that has been described recently for meas-
urement of various immunoglobulin parameters in serum and saliva
(19-23). We found that immunofluorescence signals of allergens
on the chip, allergen-specific SIgA in stool and standard IgA im-
mobilized on the chip were markedly decreased by PMSF-sensi-
tive and partly leupeptin-sensitive serine protease(s) in stool. These
results suggest that stool protease(s) degrades not only immuno-
globulin IgA and SIgA but also various allergens, such as α -casein,
β -casein, κ -casein, α - lactoalbumin, β - lactoglobulin, milk and egg
white on the chip, except ovomucoid which has an activity of serine
protease inhibitor (31).
The activities of various protease(s) in stool of neonates, infants
and toddlers and the reduction of immunofluorescence signals of
SIgA and IgA by stool protease(s) were to a large extent inhibited
by PMSF and in part by leupeptin, but not by the other inhibitors
tested in this study. The inhibitor spectrum indicates that pro-
tease(s) present in stool that degrade IgA, SIgA and allergens may
be exogenous proteases, such as IgA1, IgA2, SIgA or IgG proteases
in Escherichia coli (17, 18) and other microbiota, rather than being
leupeptin- and chymostatin-sentitive pancreatic proteases, trypsin
and chymotrypsin, respectively. In this regard, reduced IgA im-
munofluorescence signals were not detected in the stool of 3-
day-old neonates probably because of immaturity (30). On the
other hand, allergen-specific SIgA detected in the stool of 1-month-
old infants most likely originated from breast- fed milk from the
mother, which immunoreacted with milk and egg allergens. How-
ever, we cannot completely exclude the possibility that these SIgA
originated in the infant gut (Fig. 6).
The intestinal microbial abundance, diversity, and composition
change rapidly after birth by clinical, cultural, and environmental
factors, such as mode of delivery, diet, environment, family envi-
ronment, diseases, and therapies used (32). In fact, our results
showed different spectrum of protease inhibitors in the stool of
infants older than 6 months of age relative to that of neonates,
which could explain the need for additional inhibitors, such as leu-
peptin, with PMSF to produce complete inhibition of stool pro-
tease(s) of infants during growth and maturation.
In the present study, we described a new method for measure-
ment of allergen-specific SIgA in stool of neonates, infants and tod-
dlers using a sensitive DCP allergen microarray in the presence
of inhibitor cocktail, particularly with PMSF and leupeptin. The in-
hibitor cocktail may be useful not only for the analysis of allergen-
specific immunoglobulin levels but also various cytokines, in studies
Fig. 3. Effects of protease inhibitors on the reduction of immunofluo-
rescence intensity of IgA induced by stool extracts from 6-7-month-old
infants and 1-3-year -old toddlers.
Stool extracts (0.25 mg/mL) from 6-7-month-old infants (n=3) (A) and
1-3-year -old toddlers (n=4) (B) with or without protease inhibitors, 1
mM PMSF, 0.1 mM leupeptin, 0.1 mM aprotinin, 0.1 mM E-64c, 0.1 mM
bestatin, 1 mM EDTA, 0.1 mM chymostatin and inhibitor mixture de-
scribed in the text, were incubated with allergen chips for 60 min at
37and the immunofluorescence intensities of IgA (10 IU/ml) were ana-
lyzed. The imunofluorescence intensity of IgA in the absence of stool sam-
ples was set as 100%. Data represent the meanSD of the tetraplicates
spotted standard IgA.
(C) Effects of PMSF combined with other inhibitors on immunofluores-
cence intensity of IgA. Two samples with incomplete restoration of the
immunofluorescence intensity of IgA with PMSF in experiments A and
B were selected and the effects of inhibitor combination were further
analyzed. The combinations used were : 1 mM PMSF plus 0.1 mM bes-
tatin, 1 mM PMSF plus 0.1 mM leupeptin, 1 mM PMSF plus 0.1 mM E-
64-c in PBS containing 5% DMSO, 0.3 M KCl and 0.05% Tween 20. Im-
munofluorescence intensities of IgA (10 IU/ml) were analyzed. The in-
tensity of IgA in the absence of stool extract was set as 100%. Data rep-
resent the meanSD of the tetraplicates spotted standard IgA.
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designed to analyze the pathogenesis of gastrointestinal food al-
lergies in neonates, infants and toddlers.
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Fig. 4. Reduction of allergen immunoreactivity by stool protease(s) on a chip.
A : Allergen immunoreactivity was analyzed after incubation of immobilized allergen on the chips with stool of 1 -month-old infant in the presence
and absence of 1 mM PMSF for 60 min at 37. Reduction of allergen immunoreactivity was monitored using serum IgA from patients with known
egg and milk allergy. B : Reduction of allergen immunoreactivity of each allergen by stool protease(s) and its restoration by 1 mM PMSF in stool
extracts. Immunofluorescence intensity of allergen immunoreactivity was monitored as described in A. The intensity of each antigen measured in
the absence of stool extract was taken as 100% (positive control). Data represent the meanSD of the tetraplicates spotted standard IgA.
Fig. 5. Reduction of immunoreactivity of SIgA by protease(s) in stool
of 1 -3-year -old toddlers.
Stool extracts (2.5 mg/ml) free of protease inhibitors from 1-3-year -old
toddlers (n=4) were incubated for various time intervals up to 24 hr at
37and then SIgA in the stool extracts were reacted with allergens on
the chip for 60 min at 37. Representative data of SIgA immunoreac-
tivity against milk as monitored by fluorescence intensity after reaction.
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